Use of glial neurotrophic factor (GDNF) for treatment of hearing disorders
A Standard patent application filed on 14 February 1997 credited to Magal, Ella
Details
Application number :
22779
Application type :
Standard
Application status :
SEALED
Under opposition :
No
Proceeding type :
Invention title :
Use of glial neurotrophic factor (GDNF) for treatment of hearing disorders
Inventor :
Magal, Ella
Agent name :
Shelston IP
Address for service :
Level 21 60 Margaret Street SYDNEY NSW 2000
Filing date :
14 February 1997
Associated companies :
Applicant name :
Amgen, Inc.
Applicant address :
1840 Dehavilland Drive Thousand Oaks CA 91320-1789 United States Of America